Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2014
Headcount
6
HQ
Ramot HaShavim, Israel
Sector
Health Tech & Life Sciences
About
Establishment of a new field of anti-cancer treatment. Development new personalized cancer treatment, by producing new personalized autoantibodies drug specifically to every patient.
Q&A
- What is the current status of Suri Technologies?
- Suri Technologies is currently inactive, having ceased operations in December 2019.
- What was the primary focus of Suri Technologies?
- Suri Technologies focused on the establishment of a new field of anti-cancer treatment, specifically developing personalized cancer treatments by producing new personalized autoantibody drugs for individual patients.
- When was Suri Technologies founded?
- Suri Technologies was founded in January 2014.
- How many employees did Suri Technologies have?
- Suri Technologies had an employee count in the 1-10 range.
- What sector did Suri Technologies operate in?
- Suri Technologies operated primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Does Suri Technologies hold any patents?
- Yes, Suri Technologies holds 1 patent.
- Who is a key member of the founding team at Suri Technologies?
- Ilan Hochman is a Co-founder & VP R&D at Suri Technologies.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
oncologyantibodiestreatmentsdrug-developmentcancer-therapypharma-companiespersonalizationstealthmode
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2014-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Dec 2019 ceased to operate |